Browsing by Author "Han, Ji-Youn"
Now showing items 1-4 of 4
-
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer
Byers, Lauren Averett; Navarro Mendivil, Alejandro; Schaefer, Eric; Johnson, Melissa L.; Özgüroglu, Mustafa; Han, Ji-Youn (Elsevier, 2021-11) -
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Felip Font, Enriqueta (American Society of Clinical Oncology, 2020-11-01) -
Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Felip Font, Enriqueta (Elsevier, 2021-12-01) -
Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study
Park, Keunchil; Jӓnne, Pasi A.; Kim, Dong-Wan; Han, Ji-Youn; Wu, Ming-Fang; Lee, Jong-Seok; Felip Font, Enriqueta (Wiley, 2021-05-01)